
Hawkins, Inc. (NASDAQ:HWKN – Free Report) – Analysts at BWS Financial cut their Q3 2026 earnings per share (EPS) estimates for shares of Hawkins in a research note issued on Monday, November 3rd. BWS Financial analyst H. Khorsand now expects that the specialty chemicals company will post earnings of $0.73 per share for the quarter, down from their prior forecast of $0.93. BWS Financial has a “Buy” rating and a $200.00 price objective on the stock. The consensus estimate for Hawkins’ current full-year earnings is $4.00 per share. BWS Financial also issued estimates for Hawkins’ FY2026 earnings at $4.01 EPS and FY2027 earnings at $4.83 EPS.
Several other research firms also recently weighed in on HWKN. Raymond James Financial initiated coverage on Hawkins in a report on Thursday, July 24th. They issued a “market perform” rating for the company. Zacks Research downgraded Hawkins from a “strong-buy” rating to a “hold” rating in a report on Monday, September 22nd. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Hawkins in a report on Tuesday, October 14th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $162.50.
Hawkins Stock Down 1.5%
Hawkins stock opened at $128.44 on Wednesday. Hawkins has a fifty-two week low of $98.30 and a fifty-two week high of $186.15. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.45 and a current ratio of 2.31. The company has a market capitalization of $2.68 billion, a P/E ratio of 32.27, a PEG ratio of 2.25 and a beta of 0.84. The stock has a 50-day simple moving average of $168.92 and a 200-day simple moving average of $153.18.
Hawkins (NASDAQ:HWKN – Get Free Report) last announced its quarterly earnings results on Wednesday, October 29th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.24 by ($0.16). The business had revenue of $280.43 million for the quarter, compared to analysts’ expectations of $284.42 million. Hawkins had a return on equity of 17.79% and a net margin of 7.95%.
Hawkins Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 28th. Shareholders of record on Friday, November 14th will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $0.76 annualized dividend and a yield of 0.6%. Hawkins’s dividend payout ratio is currently 19.10%.
Institutional Trading of Hawkins
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Westwood Holdings Group Inc. raised its stake in shares of Hawkins by 31.5% during the 1st quarter. Westwood Holdings Group Inc. now owns 599,015 shares of the specialty chemicals company’s stock worth $63,448,000 after buying an additional 143,425 shares in the last quarter. Geode Capital Management LLC grew its holdings in Hawkins by 1.1% during the second quarter. Geode Capital Management LLC now owns 478,348 shares of the specialty chemicals company’s stock worth $67,981,000 after acquiring an additional 5,110 shares during the period. Vaughan Nelson Investment Management L.P. grew its holdings in Hawkins by 35.1% during the second quarter. Vaughan Nelson Investment Management L.P. now owns 473,752 shares of the specialty chemicals company’s stock worth $67,320,000 after acquiring an additional 123,030 shares during the period. Invesco Ltd. grew its holdings in Hawkins by 50.3% during the second quarter. Invesco Ltd. now owns 282,349 shares of the specialty chemicals company’s stock worth $40,122,000 after acquiring an additional 94,503 shares during the period. Finally, GW&K Investment Management LLC grew its holdings in Hawkins by 3.2% during the first quarter. GW&K Investment Management LLC now owns 220,327 shares of the specialty chemicals company’s stock worth $23,337,000 after acquiring an additional 6,832 shares during the period. 69.71% of the stock is owned by hedge funds and other institutional investors.
Hawkins Company Profile
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Read More
- Five stocks we like better than Hawkins
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Reasons Tesla Could Be a $500 Stock by the End of the Month
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Affirm’s New York Life Deal: A Game-Changing Stamp of Approval
- What is the Australian Securities Exchange (ASX)
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
